CSF2 and colorectal carcinoma: Moreover, KRAS mutations lead to upregulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) in TME of CRC, enhancing the infiltration of MDSCs [82] and causing an evasion of antitumor immunity.